Paxlovid Cuts Covid Death Risk. But Those Who Need It Are No

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.

Related Keywords

United States , Indiana , Florida , University Of Rochester , New York , Utah , American , Americans , Josh Fessel , Denis Nash , Brian Mcgarry , David Gifford , Drug Administration , National Institutes Of Health , Centers For Disease , Pfizer , City University Of New York , American Health Care Association , National Institutes , Pacific Northwest , Disease Control , City University , Fatalities Casualties , Paxlovid , Old Age Elderly Senior Citizens , Pharmaceuticals Prescription Drugs , Research , Nih , Us , Your Feed Healthcare ,